Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

3' Untranslated Region (UTR) Alterations Are Frequently Targeted By MM-Related Mirnas and Affects the Clinical Outcome

Mehmet K. Samur, PhD, Irtisha Singh, Lee Shih-Han, Adam Samuel Sperling, MD PhD, Mariateresa Fulciniti, PhD, Yu-Tzu Tai, PhD, Giovanni Parmigiani, PhD, Christina S. Leslie, PhD, Christine Mayr, Nikhil C Munshi, MD

Blood (2016) 128 (22): 4447.

https://doi.org/10.1182/blood.V128.22.4447.4447

Published: 2016

Journal Articles

Global 3' UTR Sequencing in Multiple Myeloma (MM)

Irtisha Singh, Mehmet K Samur, PhD, Lee Shih-Han, Adam Samuel Sperling, MD PhD, Yu-Tzu Tai, PhD, Mariateresa Fulciniti, Christina S Leslie, PhD, Christine Mayr, Nikhil C. Munshi, MD

Blood (2015) 126 (23): 2994.

https://doi.org/10.1182/blood.V126.23.2994.2994

Published: 2015

Journal Articles

Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia.

Christian P Pallasch, MD, Michaela Patz, PhD, Yoon Jung Park, PhD, Susanne Hagist, MD, Daniela Eggle, PhD, Rainer Claus, MD, Svenja Debey-Pascher, PhD, Alexandra Schulz, Lukas P Frenzel, MD, Julia Claasen, Nadine Kutsch, Günter Krause, PhD, Christine Mayr, MD, Andreas Rosenwald, MD, Christoph Plass, PhD, Joachim L Schultze, MD, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2009) 114 (22): 3463.

https://doi.org/10.1182/blood.V114.22.3463.3463

Published: 2009

Journal Articles

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

Christian Philipp Pallasch, Michaela Patz, Yoon Jung Park, Susanne Hagist, Daniela Eggle, Rainer Claus, Svenja Debey-Pascher, Alexandra Schulz, Lukas P. Frenzel, Julia Claasen, Nadine Kutsch, Günter Krause, Christine Mayr, Andreas Rosenwald, Christoph Plass, Joachim L. Schultze, Michael Hallek, Clemens-Martin Wendtner

Blood (2009) 114 (15): 3255–3264.

https://doi.org/10.1182/blood-2009-06-229898

Published: 2009

Includes: Supplemental data

Journal Articles

Occurrence of Chromosomal Translocations as Independent Prognostic Factor in Chronic Lymphocytic Leukemia.

Christine Mayr, MD, Cathrine Schulz, M.D., Stephan Stilgenbauer, M.D., Alexander Kröber, M.D., Hartmut Döhner, M.D., Ulrich Jäger, M.D., Birgit Kainz, M.D., Georg Hopfinger, M.D., Rüdiger Hoffmann, M.D., Clemens Wendtner, M.D., Michael Hallek, M.D., Michael R. Speicher, M.D.

Blood (2006) 108 (11): 2084.

https://doi.org/10.1182/blood.V108.11.2084.2084

Published: 2006

Journal Articles

Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia

Christine Mayr, Michael R. Speicher, David M. Kofler, Raymund Buhmann, John Strehl, Raymonde Busch, Michael Hallek, Clemens-Martin Wendtner

Blood (2006) 107 (2): 742–751.

https://doi.org/10.1182/blood-2005-05-2093

Published: 2006

Journal Articles

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

Christine Mayr, David M. Kofler, Hildegard Büning, Dagmar Bund, Michael Hallek, Clemens-Martin Wendtner

Blood (2005) 106 (9): 3223–3226.

https://doi.org/10.1182/blood-2005-04-1742

Published: 2005

Journal Articles

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8 + autologous T lymphocytes

Christine Mayr, Dagmar Bund, Martin Schlee, Andreas Moosmann, David M. Kofler, Michael Hallek, Clemens-Martin Wendtner

Blood (2005) 105 (4): 1566–1573.

https://doi.org/10.1182/blood-2004-04-1233

Published: 2005

Journal Articles

High Incidence of Translocations in CLL: A New Prognostic Marker for Infavorable Survival Outcome.

Christine Mayr, MD, David M. Kofler, MD, Raymund Buhmann, MD, John Strehl, MD, Raymonde Busch, Michael Hallek, MD, Clemens-Martin Wendtner, MD

Blood (2004) 104 (11): 17.

https://doi.org/10.1182/blood.V104.11.17.17

Published: 2004

Journal Articles

Fibromodulin as a Novel Tumor-Associated Antigen (TAA) in Chronic Lymphocytic Leukemia (CLL) Which Allows Expansion of Specific CD8+ Autologous T Lymphocytes.

Christine Mayr, MD, Dagmar Bund, Martin Schlee, PhD, Andreas Moosmann, PhD, Michael Hallek, MD, Clemens Wendtner, MD

Blood (2004) 104 (11): 175.

https://doi.org/10.1182/blood.V104.11.175.175

Published: 2004

NARROW

3' Untranslated Region (UTR) Alterations Are Frequently Targeted By MM-Related Mirnas and Affects the Clinical Outcome

Global 3' UTR Sequencing in Multiple Myeloma (MM)

Deregulation of miRNAs by Epigenetic Silencing Disrupts Suppression of the Oncogene PLAG1 in Chronic Lymphocytic Leukemia.

miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia

Occurrence of Chromosomal Translocations as Independent Prognostic Factor in Chronic Lymphocytic Leukemia.

Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia

Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells

Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8 + autologous T lymphocytes

High Incidence of Translocations in CLL: A New Prognostic Marker for Infavorable Survival Outcome.

Fibromodulin as a Novel Tumor-Associated Antigen (TAA) in Chronic Lymphocytic Leukemia (CLL) Which Allows Expansion of Specific CD8+ Autologous T Lymphocytes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only